Volume 29.1 of the JMCM is now available. FEATURED ARTICLES INCLUDE: Innovative Approaches in Treatment and Management of Advanced Colorectal Cancer Overcoming Barriers to the Optimal Management of Acute Myeloid Leukemia New Horizons in Acute Pain Relief: A Close Look at the Role of New and Emerging Non-Opioid Therapies
Current Issue Article:
Implementing New Data and Evolving Standards in HER2-Negative Breast Cancer: Expert Strategies on the Expanding Role of Targeted Therapy
APPROXIMATELY 300,000 CASES OF BREAST cancer are diagnosed annually in the United States.1 Hormone receptor positive disease is the most common type followed by human epidermal growth factor receptor two (HER2) positive, and then triple- negative breast cancer. Between 5 percent and 10 percent of all cases will be in patients with a breast cancer (BRCA) gene mutation.
Click Here…
